Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.5689
+0.0239 (4.39%)
Apr 29, 2025, 10:35 AM EDT - Market open
Conduit Pharmaceuticals Employees
Conduit Pharmaceuticals had 6 employees as of December 31, 2024. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,967,000
Market Cap
6.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CDT News
- 13 days ago - Conduit Pharmaceuticals Announces Leadership Changes - GlobeNewsWire
- 18 days ago - Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects - GlobeNewsWire
- 4 weeks ago - Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - GlobeNewsWire
- 5 weeks ago - Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904 - GlobeNewsWire
- 7 weeks ago - Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel - GlobeNewsWire
- 2 months ago - Conduit Progresses Phase II of its AI Initiative with Sarborg - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note - GlobeNewsWire